Graves Ophthalmopathy

Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients With Graves Disease

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Bimatoprost as a Treatment for Graves' Orbitopathy

Multi-center Prospective Clinical Study on Glucocorticoid Pulse Therapy for Graves' Ophthalmopathy (GO)

Glucocorticoids and Bone in Graves' Ophthalmopathy

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Hydroxychloroquine in Mild Graves' Orbitopathy

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy

A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy

Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

Therapeutic Efficacy of Orbital Radiotherapy in Patients With Graves' Orbitopathy

Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy

Sirolimus for Graves' Orbitopathy (GO)